Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon versus desflurane anesthesia during cardioverter defibrillator implantation
NL-OMON22512Recruiting
- Sponsor
- UZ Brussel
- Start
- Mar 2011
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of xenon and desflurane (2 arms), sponsored by UZ Brussel. Primary endpoints: Left ventricular systolic function and Left ventricular contractility. Started Mar 2011; status: recruiting.
02
Drugs
xenondesflurane
Beyond the preview
Go deeper on NL-OMON22512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22512.